Victory Pharma scores deal with Hi-Tech Pharmacal

Share this article:
Victory Pharma has inked a deal with Hi-Tech Pharmacal for exclusive US commercial license rights to its Naprelan (naproxen sodium) formulation for the treatment of arthritis. The product will be marketed through Victory's physician-based field sales force deployed throughout the US with plans for sales force expansion under way.  

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions